Single approach, multiple indications: Innovative solution to Alzheimer's disease, brain repair, and aging.
00:0010:39
OUR FOCUS
Alzheimer & Aging
OUR SCIENCE IN LAYMAN'S TERMS
ABOUT PEARL NEUROSCIENCE
🇺🇸
The Company
A powerhouse of innovation and early-stage therapeutic R&D for neurological disorders and aging. At preclinical stage and in stealth mode now, primed for a game-changing debut.
Our Therapeutic Areas
- Alzheimer's disease
- Aging
- Stroke
- Central nervous system injury
- Parkinson’s disease
- Multiple sclerosis
Single therapeutic, multiple indications. Learn more in our podcast above.
Approaches
Many causes of dementia share a common feature: they trigger neuroinflammation and disrupt the delicate brain microenvironments. Our therapeutic strategies enable neurons to thrive amid these environmental challenges, by targeting a gatekeeper of these disease triggers.
Products
We develop 1st-in-class therapeutics delivered via noninvasive nasal spray with unprecedented triple actions: curb brain degeneration, promote functional regeneration, and significantly delay aging. Learn the mechanisms in our podcast above.
Our Expertise
We are powered by decades of combined expertise in neuroscience R&D, clinical trials, companion diagnostics, regulatory strategy, IP roadmap, AI application, and supported by accomplished industry leaders.
WHAT MAKES US UNIQUE
An all-in-one approach addressing the root causes of Alzheimer's disease
Meet our AI ambassadors for company announcements. Drop a line to connect with our team.
Uniting Alzheimer's disease hypotheses
Our differentiated approach
CONNECT WITH US
CONNECT WITH PATIENTS
We integrate patient inputs into our drug development strategy. If you or your loved one is affected by age-related dementia, we'd love to hear from you!
CONNECT WITH INVESTORS
If you are investors passionate about transforming dementia and aging care through groundbreaking innovation, we'd love to explore opportunities together!